Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra

J Urol. 2001 Nov;166(5):1759-61.

Abstract

Purpose: We evaluated a multimodality approach to locally advanced urethral carcinoma in women.

Materials and methods: Between August 1996 and July 1999, 6 women were treated for locally advanced carcinoma of the urethra with anterior pelvic exenteration followed by high dose 192iridium intraoperative radiation therapy. Four of the 6 patients were also treated with neoadjuvant or concomitant platinum based chemotherapy.

Results: Two patients had no evidence of disease, 3 had distant metastasis and 2 had local recurrence at a mean followup of 21 months (range 12 to 47). Radiation was relatively well tolerated with no major adverse events.

Conclusions: High dose intraoperative brachytherapy followed by external beam radiation is relatively well tolerated. Local control seems to have improved. We must evaluate a larger cohort of patients to determine this impact of the combined modality on local control and patient survival.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy*
  • Carcinoma, Transitional Cell / drug therapy
  • Carcinoma, Transitional Cell / mortality
  • Carcinoma, Transitional Cell / radiotherapy*
  • Carcinoma, Transitional Cell / surgery*
  • Combined Modality Therapy
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Pelvic Exenteration*
  • Survival Analysis
  • Urethral Neoplasms / drug therapy
  • Urethral Neoplasms / mortality
  • Urethral Neoplasms / radiotherapy*
  • Urethral Neoplasms / surgery*